Back
Mesoblast Ltd. 10K Form
Sell
41
MESO
Mesoblast Ltd.
Last Price:
$17.22
Seasonality Move:
4.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MESO News And Ratings
See the #1 stock for the next 7 days that we like better than MESO
MESO Financial Statistics
Sales & Book Value
| Annual Sales: | $17.2M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 4.32 |
Profitability
| EPS (TTM): | -0.84610 |
|---|---|
| Net Income (TTM): | $-102.2M |
| Gross Margin: | $5.7M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Mesoblast Ltd. Earnings Forecast
Key Mesoblast Ltd. Financial Ratios
-
The Gross Profit Margin over the past 21 years for MESO is 32.96%.
-
The Selling, General & Administrative Expenses for MESO have been equal to 228.57% of Gross Profit Margin.
-
The Research & Development expenses have been 202.39% of Revenue.
-
The Net Earning history of MESO is -593.92% of Total Revenues.
-
Per Share Earnings over the last 21 years have been positive in 11 years.
Mesoblast Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MESO |
| CUSIP: | 590717 |
| Website: | mesoblast.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 99.59 |
MESO Technical Analysis vs Fundamental Analysis
Sell
41
Mesoblast Ltd. (MESO)
is a Sell
Is Mesoblast Ltd. a Buy or a Sell?
-
Mesoblast Ltd. stock is rated a SellThe current Mesoblast Ltd. [MESO] share price is $16.93. The Score for MESO is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.